cytomyx set for a sept soar? (200+product launch)

ozgem,
6.128x10^6 are being taken by institutional and other investors plus 7.6x10^6 for Clinomics purchase. These will be traded as of 13th Jan'y 2004 i.e a potential of nearly 14 million NEW ordinary shares (equivalent to 350 million shares at today's par value)
I am therefore as suprised as you by the recent increase. I would have thought there might be a small premium, say 10% but not 30% as it is at the moment

My thoughts only. But others may have a different view.

DYOR